{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:02:21Z","timestamp":1720281741032},"reference-count":32,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Gobierno de Navarra and European Union","award":["IIM10865.RI1"],"award-info":[{"award-number":["IIM10865.RI1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.01.081","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T06:29:13Z","timestamp":1328682553000},"page":"2564-2569","source":"Crossref","is-referenced-by-count":7,"title":["The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model"],"prefix":"10.1016","volume":"30","author":[{"given":"Beatriz","family":"San Rom\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximena","family":"De Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar-Mar\u00eda","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Obreg\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron-C.","family":"Asensio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mansilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Arribillaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Jos\u00e9","family":"Lasarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dami\u00e1n","family":"De Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Amorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Jes\u00fas","family":"Grill\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.01.081_bib0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/5576","article-title":"Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma","volume":"5","author":"Igarashi","year":"1999","journal-title":"Nat Med"},{"issue":"March (5359)","key":"10.1016\/j.vaccine.2012.01.081_bib0010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","article-title":"Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA","volume":"279","author":"Ogg","year":"1998","journal-title":"Science"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.01.081_bib0015","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.4049\/jimmunol.144.5.1677","article-title":"HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1","volume":"144","author":"Mills","year":"1990","journal-title":"J Immunol"},{"issue":"September (14)","key":"10.1016\/j.vaccine.2012.01.081_bib0020","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/08892220260235362","article-title":"Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets","volume":"18","author":"Dyer","year":"2002","journal-title":"AIDS Res Hum Retrovir"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2012.01.081_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198501313120502","article-title":"Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS","volume":"312","author":"Schupbach","year":"1985","journal-title":"N Engl J Med"},{"issue":"June (19)","key":"10.1016\/j.vaccine.2012.01.081_bib0030","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.vaccine.2003.11.071","article-title":"European union regulatory developments for new vaccine adjuvants and delivery systems","volume":"22","author":"Sesardic","year":"2004","journal-title":"Vaccine"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.01.081_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"April (7085)","key":"10.1016\/j.vaccine.2012.01.081_bib0040","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature04596","article-title":"Toll-dependent selection of microbial antigens for presentation by dendritic cells","volume":"440","author":"Blander","year":"2006","journal-title":"Nature"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.01.081_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9440(10)64711-6","article-title":"Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform","volume":"156","author":"George","year":"2000","journal-title":"Am J Pathol"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2012.01.081_bib0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0049-0172(00)80012-8","article-title":"Fibronectin fragments and their role in inflammatory arthritis","volume":"29","author":"Barilla","year":"2000","journal-title":"Semin Arthritis Rheum"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.01.081_bib0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4049\/jimmunol.178.2.748","article-title":"The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo","volume":"178","author":"Lasarte","year":"2007","journal-title":"J Immunol"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2012.01.081_bib0060","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The extra domain A of fibronectin activates Toll-like receptor 4","volume":"276","author":"Okamura","year":"2001","journal-title":"J Biol Chem"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.01.081_bib0065","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2009.06.005","article-title":"Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein","volume":"51","author":"Mansilla","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2012.01.081_bib0070","article-title":"Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain A from fibronectin","author":"Mansilla","year":"2011","journal-title":"Int J Cancer"},{"issue":"October (42)","key":"10.1016\/j.vaccine.2012.01.081_bib0075","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0805325105","article-title":"Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines","volume":"105","author":"Zhu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2012.01.081_bib0080","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2005-10-4015","article-title":"Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo","volume":"108","author":"Warger","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vaccine.2012.01.081_bib0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr Purif"},{"issue":"5","key":"10.1016\/j.vaccine.2012.01.081_bib0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/prep.1993.1048","article-title":"Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification","volume":"4","author":"Cheynet","year":"1993","journal-title":"Protein Expr Purif"},{"issue":"August (5259)","key":"10.1016\/j.vaccine.2012.01.081_bib0095","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.01.081_bib0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0003-2697(76)90031-2","article-title":"The visualization of human erythrocyte membrane proteins and glycoproteins in SDS polyacrylamide gels employing a single staining procedure","volume":"71","author":"King","year":"1976","journal-title":"Anal Biochem"},{"issue":"January (11\u201312)","key":"10.1016\/j.vaccine.2012.01.081_bib0105","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0264-410X(00)00379-0","article-title":"Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge","volume":"19","author":"Mata","year":"2001","journal-title":"Vaccine"},{"issue":"August (37)","key":"10.1016\/j.vaccine.2012.01.081_bib0110","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1016\/j.vaccine.2011.06.085","article-title":"Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review","volume":"29","author":"Girard","year":"2011","journal-title":"Vaccine"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2012.01.081_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1385\/MB:28:1:33","article-title":"Synthesis and assembly of SIVmac Gag p27 capsid protein cholera toxin B subunit fusion protein in transgenic potato","volume":"28","author":"Kim","year":"2004","journal-title":"Mol Biotechnol"},{"issue":"1\u20134","key":"10.1016\/j.vaccine.2012.01.081_bib0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01309705","article-title":"Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen","volume":"126","author":"Ulrich","year":"1992","journal-title":"Arch Virol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.01.081_bib0125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4049\/jimmunol.156.2.873","article-title":"Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24","volume":"156","author":"Suzue","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.01.081_bib0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-6-17","article-title":"Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli","volume":"6","author":"Donayre-Torres","year":"2009","journal-title":"Virol J"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.01.081_bib0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1467-7652.2005.00171.x","article-title":"HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production","volume":"4","author":"Obregon","year":"2006","journal-title":"Plant Biotechnol J"},{"issue":"Winter (4)","key":"10.1016\/j.vaccine.2012.01.081_bib0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/oli.2006.16.313","article-title":"Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles","volume":"16","author":"Kerkmann","year":"2006","journal-title":"Oligonucleotides"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.01.081_bib0145","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/eji.201041141","article-title":"Increased apoptosis, curtailed expansion and incomplete differentiation of CD8+ T cells combine to decrease clearance of L. monocytogenes in old mice","volume":"41","author":"Smithey","year":"2011","journal-title":"Eur J Immunol"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2012.01.081_bib0150","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.4049\/jimmunol.1001763","article-title":"IL-17A-producing gammadeltaT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation","volume":"185","author":"Xu","year":"2010","journal-title":"J Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.01.081_bib0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00002030-198905000-00004","article-title":"Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV","volume":"3","author":"Evans","year":"1989","journal-title":"AIDS"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.01.081_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00002030-199002000-00002","article-title":"Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera","volume":"4","author":"Albert","year":"1990","journal-title":"AIDS"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12001429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T11:44:44Z","timestamp":1686743084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12001429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":32,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X12001429"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}